Diabetic Patients
2
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
2
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
TakedaTAK-875
Medica CorpDLBS1449
TakedaTAK-875
TakedaTAK-875
Clinical Trials (4)
Total enrollment: 168 patients across 4 trials
Double Blind Comparative Study of TAK-875
Start: May 2012Est. completion: Dec 201280 patients
Phase 3Completed
DLBS1449 in Diabetic Patients With Low HDL
Start: Jul 2016Est. completion: Jan 20180
Phase 2/3Withdrawn
TAK-875 Glimepiride Drug-Interaction Study
Start: Jan 2012Est. completion: May 201228 patients
Phase 1Completed
Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes
Start: Jan 2009Est. completion: Jul 200960 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.